MINI FUTURE LONG - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 20:42:42 25/06/2024 BST | ||
| 1.22 EUR | 0.00% |
|
| Current month | +10.91% | ||
| 1 month | +7.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 1.22 | 0.00% |
| 24/06/24 | 1.22 | +3.39% |
| 21/06/24 | 1.18 | +6.31% |
| 20/06/24 | 1.11 | 0.00% |
| 19/06/24 | 1.11 | +1.83% |
Delayed Quote Börse Stuttgart
Last update June 25, 2024 at 08:42 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MB94KQ |
| ISIN | DE000MB94KQ6 |
| Date issued | 24/07/2023 |
| Strike | 29.15 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.24 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.38 € |
|---|---|
| Lowest since issue | 1.04 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.19
USD
Average target price
53.19
USD
Spread / Average Target
+26.08%
- Stock Market
- Certificates
- Certificat
